Jupiter Research Capital (Asia) Ltd’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$308K Sell
2,533
-17,868
-88% -$2.1M 0.03% 484
2026
Q2
$2.06M Buy
20,401
+17,170
+531% +$1.78M 0.23% 88
2026
Q1
$313K Sell
3,231
-3,276
-50% -$336K 0.03% 505
2025
Q4
$691K Buy
+6,507
New +$754K 0.14% 195

Other funds holding EHC

Jupiter Research Capital (Asia) Ltd's EHC Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd reduced its Encompass Health (EHC) stake by 88% in Q3 2026, selling an estimated $2.1M and leaving 2,533 shares worth $308K. The position accounts for 0.03% of the portfolio, ranked #484.

Jupiter Research Capital (Asia) Ltd first reported a position in EHC in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.06M in Q2 2026. 611 funds tracked by Wall St. Rank hold EHC as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 2,533 shares of Encompass Health worth $308K as of Q3 2026.
  • Jupiter Research Capital (Asia) Ltd sold 17,868 Encompass Health shares in Q3 2026, an estimated $2.1M.
  • Encompass Health made up 0.03% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #484 holding.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Encompass Health in Q4 2025 and has held it in 4 quarters since.
  • Jupiter Research Capital (Asia) Ltd's Encompass Health position peaked at $2.06M in Q2 2026.
  • 611 funds tracked by Wall St. Rank held Encompass Health as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.